Literature DB >> 7329902

Hydrallazine alone in acute left ventricular failure.

A J Clark, H B McMichael.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7329902      PMCID: PMC2426154          DOI: 10.1136/pgmj.57.671.602

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Vasodilator treatment for acute and chronic heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  Br Heart J       Date:  1977-07

2.  Hydralazine in the management of left ventricular failure.

Authors:  D H Fitchett; J A Neto; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1979-08       Impact factor: 2.778

3.  Drugs and the heart. VI. Vasodilating drugs.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-05-03       Impact factor: 79.321

Review 4.  Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.

Authors:  D T Mason
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

5.  Oral hydralazine therapy for chronic refractory heart failure.

Authors:  K Chatterjee; W W Parmley; B Massie; B Greenberg; J Werner; S Klausner; A Norman
Journal:  Circulation       Date:  1976-12       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.